Clinical trials
Recruiting Obesity trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 8 |
| Amgen | 4 |
| AstraZeneca | 3 |
| Novo Nordisk A/S | 3 |
| Hoffmann-La Roche | 2 |
| Pfizer | 2 |
| Chiba University | 1 |
| Osaka Metropolitan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 24 |
| Overweight | 19 |
| Diabetes Mellitus, Type 2 | 8 |
| Atherosclerosis | 3 |
| Diabetes Mellitus | 2 |
| Heart Failure | 2 |
| Hypertension | 2 |
| Renal Insufficiency, Chronic | 2 |
| Sleep Apnea, Obstructive | 2 |
| Body Weight | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.